ZEISS Receives CE Mark Approval for Innovative AI Tool in Ophthalmology ZEISS Medical Technology secures CE mark for CIRRUS PathFinder, revolutionizing OCT assessments with AI support for enhanced diagnostic confidence.

ZEISS Receives CE Mark Approval for Innovative AI Tool in Ophthalmology #Germany #AI_Diagnostics #Jena #ZEISS_Medical_Technology #CIRRUS_PathFinder

ZEISS Medical Technology: Revolutionizing Intraoperative Radiotherapy with INTRABEAM 700 ZEISS Medical Technology has received FDA clearance for its innovative INTRABEAM 700 platform, enhancing treatments for brain tumors and breast cancer with smart, robotic-assisted workflows.

ZEISS Medical Technology: Revolutionizing Intraoperative Radiotherapy with INTRABEAM 700 #Germany #cancer_therapy #Jena #ZEISS_Medical_Technology #INTRABEAM_700